日本語English简体中文 繁體中文

6029 Artra Group CorporationアトラグループTSE Standard / Services

0 posts

Artra Group Corporation (6029) at a glance

Code
6029
Company
Artra Group Corporation
Local name
アトラグループ
Market
TSE Standard
Sector
Services
Share price
¥167 -5.0 (-2.91%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Artra Group Corporation (6029) Stock Price History

Artra Group Corporation closed at ¥167 on Nov 20, 2026, −10.7% over 1 month, +3.7% over 1 year.

2026-11-13 業績予想の修正に関するお知らせ / 2026年12月期 第3四半期決算短信〔日本基準〕(連結)2026-11-17 REMED JAPAN株式会社との資本業務提携及び第三者割当増資の引受けによる同社株式取得…¥229¥155Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥229Oct 30
1-Month Low¥155Nov 6
1-Week Change−10.2%vs Nov 13
1-Month Change−10.7%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥89,305 today (−10.7%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −10.7%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥167−5−2.91%
Nov 19 (Thu)¥172−3−1.71%
Nov 18 (Wed)¥175+5+2.94%
Nov 17 (Tue)¥170−9−5.03%
Nov 16 (Mon)¥179−7−3.76%
Nov 13 (Fri)¥186+1+0.54%
Nov 12 (Thu)¥185+11+6.32%
Nov 11 (Wed)¥174+3+1.75%
Nov 10 (Tue)¥171+6+3.64%
Nov 9 (Mon)¥165+10+6.45%
2026-11-13 業績予想の修正に関するお知らせ / 2026年12月期 第3四半期決算短信〔日本基準〕(連結)2026-11-17 REMED JAPAN株式会社との資本業務提携及び第三者割当増資の引受けによる同社株式取得…¥229¥155Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥229Oct 30
3-Month Low¥155Nov 6
1-Month Change−10.7%vs Oct 20
3-Month Change−13.0%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥86,979 today (−13.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −13.0%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥167−5−2.91%
Nov 19 (Thu)¥172−3−1.71%
Nov 18 (Wed)¥175+5+2.94%
Nov 17 (Tue)¥170−9−5.03%
Nov 16 (Mon)¥179−7−3.76%
Nov 13 (Fri)¥186+1+0.54%
Nov 12 (Thu)¥185+11+6.32%
Nov 11 (Wed)¥174+3+1.75%
Nov 10 (Tue)¥171+6+3.64%
Nov 9 (Mon)¥165+10+6.45%
2026-11-13 業績予想の修正に関するお知らせ / 2026年12月期 第3四半期決算短信〔日本基準〕(連結)2026-11-17 REMED JAPAN株式会社との資本業務提携及び第三者割当増資の引受けによる同社株式取得…¥229¥155May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥229Oct 30
6-Month Low¥155Nov 6
3-Month Change−13.0%vs Aug 20
6-Month Change−17.3%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥82,673 today (−17.3%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −17.3%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥167−27.1%
Oct 2026¥229+19.9%
Sep 2026¥191+2.7%
Aug 2026¥186−4.1%
Jul 2026¥194+3.7%
Jun 2026¥187−10.5%
May 2026¥209+18.1%
2026-11-13 業績予想の修正に関するお知らせ / 2026年12月期 第3四半期決算短信〔日本基準〕(連結)2026-11-17 REMED JAPAN株式会社との資本業務提携及び第三者割当増資の引受けによる同社株式取得…¥229¥136Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥229Oct 30
52-Week Low¥136Mar 4
Year to Date−1.8%vs Dec 30
From 52-Week High−27.1%Oct 30

If you had invested ¥100,000 1 year ago, it would be worth ¥103,727 today (+3.7%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved +3.7%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥167−27.1%
Oct 2026¥229+19.9%
Sep 2026¥191+2.7%
Aug 2026¥186−4.1%
Jul 2026¥194+3.7%
Jun 2026¥187−10.5%
May 2026¥209+18.1%
Apr 2026¥177+22.9%
Mar 2026¥144−5.9%
Feb 2026¥153−11.0%
Jan 2026¥172+1.2%
Dec 2025¥170−1.2%
Nov 2025¥172―
¥335¥122Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥335Aug 11, 2025
3-Year Low¥122Jan 13, 2025
Annualized Return−5.2%
Max Drawdown−57.6%

If you had invested ¥100,000 3 years ago, it would be worth ¥85,204 today (−14.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved −14.8%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥167−1.8%
2025¥170―
¥335¥122Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥335Aug 11, 2025
5-Year Low¥122Jan 13, 2025
Annualized Return−10.5%
Max Drawdown−60.5%

If you had invested ¥100,000 5 years ago, it would be worth ¥57,586 today (−42.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved −42.4%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥167−1.8%
2025¥170―
¥1,471¥122Jan 1, 2015Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥1,471Jul 2016
All-Time Low¥122Feb 2025
Total Change−22.0%vs Jan 2015
Annualized Return−2.1%

If you had invested ¥100,000 in Jan 2015, it would be worth ¥78,037 today (−22.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +193.8%, while this stock moved −22.0%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥167−1.8%
2025¥170+25.9%
2024¥135−28.9%
2023¥190+1.6%
2022¥187−35.5%
2021¥290−5.5%
2020¥307−15.4%
2019¥363−11.5%
2018¥410−42.7%
2017¥716−1.2%
2016¥725−41.1%
2015¥1,231―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jan 2015). Please check the latest prices before trading.

Artra Group Corporation (6029) financial indicators

PER
9.8
PBR
0.95
ROE
9.72%
Dividend yield
0.00%

See all financial indicators for Artra Group Corporation (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of Artra Group Corporation (6029)

Business overview

Under the philosophy "we want to make people all over the world healthy," the company runs the A-COMS business, which supports the management of osteopathic and acupuncture clinics, and a toy sales business. In the acupuncture and osteopathic clinic industry, insurance-covered treatment fees are declining, making the expansion of self-paid treatment and product sales a key challenge. The A-COMS business treats its management support platform, centered on the A-COMS core system for clinics, as its growth pillar, and also holds seminars on topics such as self-paid treatment through Atla Academy. It has five subsidiaries.

Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.

Position within Services (532 companies)

PER9.8xBelow the sector median of 12.9x (No. 130 from the lowest)
PBR0.95xBelow the sector median of 1.49x (No. 118 from the lowest)
ROE9.72%No. 280 in the sector (highest first); median 12.16%
Market cap¥1.8 bnNo. 479 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥22910/30
52-week low¥1363/4
Current position33.3%Where the low is 0% and the high is 100% (close on 11/20: ¥167)
Year to date-1.8%No. 158 of 524 in the sector (best first)
1 year+3.7%

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 gainers2 timesLatest: 11/12 (No. 48)
Top 50 losers2 timesLatest: 11/4 (No. 20)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (5).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the Artra Group Corporation board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English